Aiwei Pharma

Aiwei Pharma

艾威药业

Aiwei Pharma

Biotech/Healthcare

Aiwei Pharmaceuticals is an ophthalmic innovative drug developer conducting R&D and drug registration filings in both China and the United States. Its core team consists of scientists and clinicians from China and the U.S.

Latest round: Series A Extension (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-01-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.